Testing effectiveness (Phase 2)Study completedNCT02311673
What this trial is testing
Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome
Who this might be right for
Prader-Willi Syndrome
Rhythm Pharmaceuticals, Inc. 40